Variant within CELSR2/PSRC1/SORT1, but not within CILP2/PBX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy

Journal of Applied Biomedicine

Jitka Rynekrova¹  Michal Vrablik¹  Lukas Zlatohlavek¹  Richard Ceska¹  Jaroslav Alois Hubacek¹  Dana Dlouha¹  Vera Lanska¹  Vera Adamková¹  Martina Prusikova¹ 

关键词: dyslipidemia;    statins;    gene variants;    pharmacogenetics;    treatment efficacy;    CELSR2/PSRC1/SORT1;    CILP2/PBX4;    PCSK9;    APOB;   

DOI  :  

学科分类：医学（综合）

来源: Elsevier

【 摘 要 】

AcademicJournalsDatabaseisauniversalindexofperiodicalliteraturecoveringbasicresearchfromallfieldsofknowledge,andisparticularlystronginmedicalresearch,humanitiesandsocialsciences.Full-textfrommostofthearticlesisavailable.AcademicJournalsDatabasecontainscompletebibliographiccitations,preciseindexing,andinformativeabstractsforpapersfromawiderangeofperiodicals.

【 授权许可】

Unknown